Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 56:10)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004133 AN006851 Metabolite profiling of portal and cardiac puncture plasma in C57Bl6 mice treated with Vancomycin or Metronidazole under a regular or high fat diet. Blood Mouse Diabetes Broad Institute of MIT and Harvard LC-MS
ST004110 AN006813 Lipidomics characterization from plasma VLDL fractions isolated from human PNPLA3 wild type and human PNPLA3(I148M) knock in mice. Blood Mouse Liver disease Amgen LC-MS
ST004095 AN006788 Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics Cultured cells Human Cancer Amgen LC-MS
ST003913 AN006425 Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting Blood Human MaineHealth Institute for Research LC-MS/MS(Dir. Inf.)
ST003913 AN006425 Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting Bone marrow serum Human MaineHealth Institute for Research LC-MS/MS(Dir. Inf.)
ST003814 AN006271 Sulfur Amino Acid Restriction Enhances Exercise Capacity in Mice by Boosting Fat Oxidation in Muscle - extensor digitorum longus (EDL) versus soleus (Sol) on Con and SAAR diet lipidomics Muscle Mouse Princeton University LC-MS
ST003776 AN006202 Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion Liver Mouse Environmental exposure University of Bonn LC-MS
ST003702 AN006074 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO Liver Mouse University of Bonn LC-MS
ST003614 AN005939 Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion Liver Mouse University of Bonn LC-MS
ST003528 AN005795 Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma Liver Mouse Cancer University of Utah LC-MS
ST003522 AN005784 Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice Adipose tissue Mouse Cancer Stanford University LC-MS
ST003522 AN005784 Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice Tumor tissue Mouse Cancer Stanford University LC-MS
ST003456 AN005677 Lipidomics of human serum to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part2 human lipids) Blood Human Sepsis Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute LC-MS
ST003293 AN005392 High Fat Feeding Alters Circulating Triglyceride Profile by Decreasing SCD Activity and Depleting omega-3 Fatty Acids Blood Rat Hyperlipidemia University of Southern California LC-MS
ST003157 AN005179 Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics Blood Mouse Multiple sclerosis University of Luebeck LC-MS
ST003090 AN005054 Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B Cultured cells Mouse Rutgers University LC-MS
ST002903 AN004764 Identification and targeting of microbial putrescine acetylation in bloodstream infections Blood Human Septic shock Broad Institute of MIT and Harvard LC-MS
ST002843 AN004652 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) Liver Mouse Cancer Rutgers University LC-MS
ST002843 AN004653 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) Liver Mouse Cancer Rutgers University LC-MS
ST002842 AN004651 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) Liver Mouse Cancer Rutgers University LC-MS
ST002824 AN004608 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia Blood Mouse Cancer Rutgers University LC-MS
ST002813 AN004577 Effects of acute cold exposure on mouse metabolome BAT Mouse University of Pennsylvania LC-MS
ST002813 AN004577 Effects of acute cold exposure on mouse metabolome Blood Mouse University of Pennsylvania LC-MS
ST002813 AN004577 Effects of acute cold exposure on mouse metabolome Diaphragm Mouse University of Pennsylvania LC-MS
ST002813 AN004577 Effects of acute cold exposure on mouse metabolome gWAT Mouse University of Pennsylvania LC-MS
ST002813 AN004577 Effects of acute cold exposure on mouse metabolome Heart Mouse University of Pennsylvania LC-MS
ST002813 AN004577 Effects of acute cold exposure on mouse metabolome Liver Mouse University of Pennsylvania LC-MS
ST002813 AN004577 Effects of acute cold exposure on mouse metabolome Quadriceps Mouse University of Pennsylvania LC-MS
ST002764 AN004499 Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort Blood Human Cancer Icahn School of Medicine at Mount Sinai LC-MS
ST002729 AN004426 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Muscle Mouse Diabetes Medical Institute of Bioregulation, Kyushu University LC-MS
ST002700 AN004376 Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics Blood Human Autism Columbia University LC-MS
ST002470 AN004030 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002135 AN003496 Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples. (Part 2) Blood Human University of Michigan LC-MS
ST002134 AN003492 Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples (Part 1) Blood Human University of Michigan LC-MS
ST002057 AN003349 Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis Cultured cells Human NASH Monash Institute of Pharmaceutical Sciences LC-MS
ST002002 AN003265 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University LC-MS
ST001950 AN003174 Lipidome Alterations Following Mild Traumatic Brain Injury. Blood Rat Traumatic brain injury Georgia Institute of Technology LC-MS
ST001949 AN003173 Plasma Metabolome Normalization in Rheumatoid Arthritis following initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy Blood Human Rheumatoid arthritis University of Kansas GC-MS
ST001521 AN002534 Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) Blood Human Broad Institute of MIT and Harvard LC-MS
ST001451 AN002426 Eleostearic acid effects on TAGs and oxLipids Breast cancer cells Human Cancer Fox Chase Cancer Center LC-MS
ST001292 AN002149 Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. Kidney Mouse Diabetes University of Michigan LC-MS
ST001286 AN002130 Lipid composition of isolated lipid droplets from the functional bovine corpus luteum Ovaries Cow University of Nebraska Medical Center LC-MS
ST001275 AN002116 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST001269 AN002109 Exosomal lipids for classifying early and late stage non-small cell lung cancer Blood Human Cancer University of Kentucky MS(Dir. Inf.)
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001067 AN001746 Lipidomics analysis for aged mice femoral muscle (part - IV) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001066 AN001744 Lipidomics analysis for aged mice liver (part-III) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001065 AN001742 Lipidomics analysis for aged mice brain cortex (part-II) Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001063 AN001739 Lipidomics analysis for aged mice organs Adipose tissue Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001063 AN001739 Lipidomics analysis for aged mice organs Brain Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001063 AN001739 Lipidomics analysis for aged mice organs Liver Mouse Takeda Pharmaceutical Company Limited LC-MS
ST001063 AN001739 Lipidomics analysis for aged mice organs Muscle Mouse Takeda Pharmaceutical Company Limited LC-MS
ST000992 AN001621 Metabolomic Markers of Dietary Patterns in the Costa Rica Study Blood Human Metabolic syndrome University of Michigan LC-MS
ST000991 AN001617 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) Blood Human University of California, Davis LC-MS
ST000990 AN001616 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) Blood Human University of California, Davis LC-MS
ST000989 AN001615 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) Blood Human University of California, Davis LC-MS
ST000988 AN001614 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) Blood Human University of California, Davis LC-MS
ST000987 AN001613 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) Blood Human University of California, Davis LC-MS
ST000986 AN001612 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) Blood Human University of California, Davis LC-MS
ST000985 AN001611 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) Blood Human University of California, Davis LC-MS
ST000984 AN001610 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) Blood Human University of California, Davis LC-MS
ST000983 AN001609 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) Blood Human University of California, Davis LC-MS
ST000818 AN001299 Integrated nutrigenomic and metabolomic analysis of Africans with variable diet Blood Human Heart disease University of Michigan LC-MS
ST000781 AN001237 Rabbit Plasma Lipidomics with high fat diet and treatment Blood Rabbit University of Michigan LC-MS
ST000779 AN001233 Lipidomics pilot project for mice exposure to bisphenol A and high fat diets Blood Mouse Fatty liver disease University of Michigan LC-MS
ST000778 AN001231 Rat Colon Study effect of Effect of fish oil on azoxymethane (AOM) Colon Rat University of Michigan LC-MS
ST000775 AN001225 Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study Blood Human Depression University of Michigan LC-MS
ST000763 AN001204 Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort Blood Human Scleroderma University of Michigan LC-MS
ST000759 AN001197 Age and exercise effect on metabolomics in rats Unspecified Rat University of Michigan LC-MS
ST000743 AN001162 Metabolomics of bariatric weight loss Unspecified Human Diabetes University of Michigan LC-MS
ST000708 AN001102 Metabolic effects of weight reduction of very low energy diet vs dietary counseling Unspecified Human University of Michigan LC-MS
ST000695 AN001078 Pilot metabolomics study of aromatase inhibitor associated arthralgias Blood Human Arthralgia University of Michigan LC-MS
ST000688 AN001062 Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) Unspecified Human Multiple sclerosis University of Michigan LC-MS
ST000686 AN001059 Lipodomics and Gestational bisphenol A (BPA) exposure Unspecified Sheep University of Michigan LC-MS
ST000685 AN001057 Lipidomics analysis for human liver cell lines Cultured cells Human University of Michigan LC-MS
ST000677 AN001041 Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrations Blood Human Fatty liver disease University of Michigan LC-MS
ST000676 AN001039 Effect of high fat diet and streptozotocin treatment on neuropathy Blood Mouse Neuropathy University of Michigan LC-MS
ST000674 AN001035 Bmal1-ethanol based diet and liver injury Liver Mouse University of Michigan LC-MS
ST000673 AN001033 Lipidomics in (SIDS) Sudden Infant Death Syndrome Blood Human Sudden infant death syndrome University of Michigan LC-MS
ST000672 AN001031 Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison (part II) Blood Mouse Diabetes University of Michigan LC-MS
ST000670 AN001027 Exposure to high fat diets and bisphenol Blood Mouse University of Michigan LC-MS
ST000669 AN001025 Characterization of Retinal Exudates in Coats Disease - lipid profile Eye tissue Human Eye disease University of Michigan LC-MS
ST000668 AN001023 Diet manipulation on the lipidome Blood Human University of Michigan LC-MS
ST000667 AN001021 Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison Blood Mouse Diabetes University of Michigan LC-MS
ST000666 AN001019 Rat Rotator Cuff Lipidomics Muscle Rat University of Michigan LC-MS
ST000664 AN001015 Nutritional Psychiatric Illness Studies Blood Human Bipolar I Disorder University of Michigan LC-MS
ST000663 AN001013 Metabolic Syndrome Plasma Lipidomics Blood Human Metabolic syndrome University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Human Obesity University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Rat Obesity University of Michigan LC-MS
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky LC-MS
ST000114 AN000192 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000113 AN000190 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Positive ion mode FTMS) B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo